Comparison of pyrazinamide drug susceptibility of M.tuberculosis by radiometric bactec and enzymatic pyrazinamidase assay

Indian Journal of Medical Microbiology

Volumn 22, Issue 3, 2004, Pages 166-168

  Krishnamurthy, A ^a   Almeida, D ^a   Rodrigues, C ^a   Mehta, A ^a  

^a P D HINDUJA NATIONAL HOSPITAL   (India)

Author keywords

Lowenstein Jensen method; Pyrazinamidase assay; Pyrazinamide; TB BACTEC

Indexed keywords

PYRAZINAMIDE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CONTROLLED STUDY; ENZYMATIC ASSAY; INTERMETHOD COMPARISON; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; RADIOMETRY; SENSITIVITY AND SPECIFICITY;

EID: 4444293114     PISSN: 02550857     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Scorpio A, Lindholm-Levy P, Heifets L, Gilman R, Siddiqi S, Cynamon M, Zhang Y. Characterization of pncA mutations in pyrazinamide-resistant Mycobacterium tuberculosis. Antimicrob Agents Chemother 1997;41:540-543.
2. Davies AP, Billington OJ, McHugh TD, Mitchison DA, Gillespie SH. Comparison of phenotypic and genotypic methods for pyrazinamde susceptibility testing with Mycobacterium tuberculosis. J Clin Microbiol 2000;38:3686-3688.
3. Raynaud C, Laneelle M, Ryan HS, Draper P, Laneelle G, Daffe M. Mechanisms of pyrazinamide resistance in mycobacteria: importance of lack of uptake in addition to lack of pyrazinamidase activity. Microbiol 1999;145:1359-1367.
4. Heifets LB, Iseman MD. Radiometric method for testing susceptibility of mycobacteria to pyrazinamide in 7H12 broth. J Clin Microbiol 1985;21:200-204.
5. Eltringham IJ, Wilson SM, Drobniewski FA. Evaluation of a bacteriophage-based assay (Phage Amplified Biologically Assay) as a rapid screen for resistance to isoniazid, ethambutol, streptomycin, pyrazinamide and ciprofloxacin among clinical isolates of Mycobacterium tuberculosis. J Clin Microbiol 1999;37:3528-3532.
6. Miller MA, Thibert L, Desjardins F, Siddiqi SH, Dascal A. Testing of susceptibility of Mycobacterium tuberculosis to pyrazinamide: Comparison of BACTEC method with Pyrazinamidase assay. J Clin Microbiol 1995;33:2468-2470.
7. Siddiqi S. 1996. BACTEC 460 TB System, Product and Procedure manual. Revision E. Becton Dickinson Microbiology Systems, Sparks, Md.
8. Canetti G, Fox W, Khomenko A, Mahler HT, Menon NK, Mitchison DA, Rist N, Smelev NA. Advances in techniques of testing, mycobacterial drug sensitivity, and the use of sensitivity tests in Tuberculosis Control Programmes. Bull World Health Organ 1969;41:21-43.
9. Kent PT, Kubica GP. Public health mycobacteriology. A guide for the level III laboratory. Centers for Disease Control, Atlanta, Ga. 1985;71-120.
10. Keihn T E, Cynamon MH, Inderlied CB, Roberts GD, Siddiqi SH, Wallace RJ, Warren NG. NCCLS. Susceptibility testing of mycobacteria, nocardia and other aerobic actinomycetes; tentative standard, 2nd Edn. NCCLS document M24-T24, NCCLS, 1995;15(16); Wayne, Pa.
11. Miller MA, Thibert L, Desjardins F, Siddiqi SH, Dascal A. Growth inhibition of Mycobacterium tuberculosis by Polyoxyethylene stearate present in the BACTEC Pyrazinamide susceptibility test. J Clin Microbiol 1996;34:84-86.